Bone Density Loss: Tenofovir is connected to a decrease in bone mineral density, growing the potential risk of bone problems or fractures.Administration of substantial doses of tenofovir continues to be described to provide bone toxicity documented as osteomalacia and lessened bone mineral density and to provide some diploma of renal toxicity.Insom